Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Glycemic Status on Ciprofloxacin Response in T2DM Patients With Recurrent UTI
NCT07188935Completed
- Sponsor
- Al-Mustansiriyah University
- Start
- Oct 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ciprofloxacin in urinary tract infection (UTI) (2 arms), sponsored by Al-Mustansiriyah University. Primary endpoints: Treatment Success (Absence of Symptoms and Pus Cells <5/HPF) at 14 days and Treatment Success at 30 Days. Started Oct 2024; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07188935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07188935.